The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy
Status:
Terminated
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of our study is primarily to evaluate the effects of 5mg finasteride on hematuria
and hematospermia commonly associated with prostate biopsies. We hypothesize that 5mg of
finasteride daily for two weeks preceding TRUS prostate biopsy and one week following will
reduce hematuria and hematospermia commonly seen as complications following prostate biopsy.
We also hypothesize that reducing complications will decrease concern among subjects and make
for a more tolerable overall procedure than compared with subjects treated with placebo.